Massive Transfusion Protocol Guidelines

Core Definition and Activation

A massive transfusion protocol (MTP) is a standardized, pre-established institutional algorithm that enables rapid delivery of blood products in fixed ratios to patients experiencing life-threatening hemorrhage, activated immediately when massive bleeding is anticipated or confirmed, according to the American Society of Anesthesiologists 1, 2
Hospitals must have an MTP in place that includes clinical, laboratory, and logistic responses, as recommended by the American College of Surgeons 1, 2
The protocol is typically activated when 1-1.5 blood volumes may need to be infused acutely or within a 24-hour period, as suggested by the American Association of Blood Banks 1, 2
The traditional definition involves transfusion of ≥10 units of packed red blood cells within 24 hours, though this occurs in less than 2% of civilian trauma patients, according to the Society of Critical Care Medicine 4, 5
The nature of injury alerts clinicians to probable massive hemorrhage before formal thresholds are met, as stated by the American College of Emergency Physicians 1, 2

The MTP requires designated team roles, including a team leader, communications lead, dedicated personnel, and IV access specialist, as recommended by the American Society of Anesthesiologists 1, 2
The team leader, usually the most senior physician, declares the massive hemorrhage situation and coordinates management, according to the American College of Surgeons 1

The cornerstone of modern MTPs is early administration of blood products in balanced ratios, specifically 1:1:1 of RBC:FFP:platelets, based on military experience showing improved survival, as recommended by the Society of Critical Care Medicine 4, 5
Begin early FFP administration at 10-15 ml/kg to prevent dilutional coagulopathy before it develops, as suggested by the American Association of Blood Banks 5
Maintain platelet count ≥75 × 10⁹/L throughout resuscitation, according to the American Society of Hematology 3, 6
Use warmed blood products—start with O-negative blood if needed immediately, then transition to group-specific or cross-matched blood, as recommended by the American College of Surgeons 3, 6

MTPs must address both clinical management and logistics to deliver blood products rapidly to the patient while organizing definitive hemorrhage control, as stated by the American Society of Anesthesiologists 1, 2
Immediate control of obvious bleeding through direct pressure, tourniquets, or hemostatic dressings is essential, according to the American College of Surgeons 3, 6
High FiO₂ administration and securing large-bore IV access are critical, as recommended by the American College of Emergency Physicians 3, 6

Target fibrinogen levels >1 g/L using fibrinogen concentrate or cryoprecipitate, as fibrinogen <1 g/L represents established hemostatic failure and predicts microvascular bleeding, according to the American Society of Hematology 3, 6
The most effective rapid fibrinogen replacement is achieved with fibrinogen concentrate or cryoprecipitate, as stated by the American Association of Blood Banks 3, 6

Once bleeding is controlled, aggressively normalize blood pressure, acid-base status, and temperature, then admit to critical care for ongoing monitoring, as recommended by the Society of Critical Care Medicine 3, 6
Initiate standard venous thromboprophylaxis as soon as hemostasis is secured, as patients rapidly develop a prothrombotic state following massive hemorrhage, according to the American College of Chest Physicians 2, 3, 6